0 CHECKOUT

PRODUCT FILTERS

REGION

31
5
3
3
2

COUNTRY

3
2
1
1
1

CATEGORIES

  • 15
  • 12
  • 11
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

7
9
20
73

PUBLISHED

1
5
27
73

PRODUCT TYPE

63
7
3

Search for: "General Pharmaceuticals Ltd.-Therapeutic Competitors Report"

Global Alzheimer's Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022

Alzheimer’s therapeutics market was esteemed at USD 8,524.9 Mn in 2015, and is relied upon to achieve USD 14,856.3 Mn by 2022, growing at a CAGR of 8.02% from 2016 to 2022. Market Insights: Alzheimer’s...

Published:  May 2016
Price:  From

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered...

Published:  April 2014
Price:  From

Hypertension - Pipeline Review, H2 2015

Hypertension - Pipeline Review, H2 2015 Summary The report ‘Hypertension - Pipeline Review, H2 2015’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market

GBI Research, the leading business intelligence provider, has released its latest research, “Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome...

Published:  November 2012
Price:  From

Glaucoma - Pipeline Review, H2 2015

Glaucoma - Pipeline Review, H2 2015 Summary The report ‘Glaucoma - Pipeline Review, H2 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2015
Price:  From

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  January 2015
Price:  From

Glaucoma - Pipeline Review, H1 2015

Glaucoma - Pipeline Review, H1 2015 Summary This, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

Published:  January 2015
Price:  From

Sedation - Pipeline Review, H2 2016

Sedation - Pipeline Review, H2 2016 Summary ‘Sedation - Pipeline Review, H2 2016’, provides an overview of the Sedation pipeline landscape. The report provides comprehensive information on the therapeutics...

Published:  July 2016
Price:  From

Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review

Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  May 2016
Price:  From

Sedation - Pipeline Review, H1 2016

Sedation - Pipeline Review, H1 2016 Summary The report ‘Sedation - Pipeline Review, H1 2016’, provides an overview of the Sedation pipeline landscape. The report provides comprehensive information...

Published:  February 2016
Price:  From

Candidiasis - Pipeline Review, H1 2016

Candidiasis - Pipeline Review, H1 2016 Summary ‘Candidiasis - Pipeline Review, H1 2016’, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive information...

Published:  February 2016
Price:  From

Breast Cancer - Pipeline Review, H2 2015

Breast Cancer - Pipeline Review, H2 2015 Summary The report ‘Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Anesthetic Effect - Pipeline Review, H1 2016

Anesthetic Effect - Pipeline Review, H1 2016 Summary ‘Anesthetic Effect - Pipeline Review, H1 2016’, provides an overview of the Anesthetic Effect pipeline landscape. The report provides comprehensive...

Published:  April 2016
Price:  From

Bacterial Conjunctivitis - Pipeline Review, H2 2015

Bacterial Conjunctivitis - Pipeline Review, H2 2015 Summary The report ‘Bacterial Conjunctivitis - Pipeline Review, H2 2015’, provides an overview of the Bacterial Conjunctivitis’s therapeutic pipeline. This...

Published:  November 2015
Price:  From

Candidiasis - Pipeline Review, H2 2015

Candidiasis - Pipeline Review, H2 2015 Summary The report ‘Candidiasis - Pipeline Review, H2 2015’, provides an overview of the Candidiasis’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2015
Price:  From

Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review

Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

Published:  February 2016
Price:  From

Anesthetic Effect - Pipeline Review, H2 2015

Anesthetic Effect - Pipeline Review, H2 2015 Summary The report ‘Anesthetic Effect - Pipeline Review, H2 2015’, provides an overview of the Anesthetic Effect’s therapeutic pipeline. This report provides...

Published:  October 2015
Price:  From

Sedation - Pipeline Review, H1 2015

Sedation - Pipeline Review, H1 2015 Summary This, ‘Sedation - Pipeline Review, H1 2015’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information...

Published:  January 2015
Price:  From

The World Market for Orphan Drugs (Markets for Oncology, Hematology, Neurology, Endocrine, Metabolic and Other Drugs)

In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this...

Published:  June 2013
Price:  From

OTC Distribution in Europe 2016 Edition: The New Global Agenda

OTC Distribution in Europe - the 2016 edition is an in-depth strategic analysis that defines and explores the main themes of change running through the European region and shows how they will influence...

Published:  January 2016
Price:  From
Loading Indicator

Our Clients

  • Credit Suisse Group
  • Heinz Company
  • Telenor Group
  • Deutsche Bank AG
  • Solvay S.A.
  • APC by Schneider Electric
  • Lindt & Sprüngli AG